Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.9K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.9K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

623
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
623
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

746
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
746

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuation of anti-tuberculosis therapy after Clostridioides difficile infection: a retrospective cohort study.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Unexpected Response to Nab-Paclitaxel in Poor Performance Status Lung Adenocarcinoma With a Unique 'Pan-Positive' Tumour Marker Profile: Case Report.

Respirology case reports·2025
Same author

Serum cytokine analysis in cavitary and non-cavitary pulmonary Mycobacterium avium complex disease: a cross-sectional study.

BMC infectious diseases·2025
Same author

Serum Type 2 Cytokine Levels Are Elevated in a Chronic Pulmonary Aspergillosis Subgroup with High Serum Total Immunoglobulin E Level.

Journal of fungi (Basel, Switzerland)·2025
Same author

Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

Cancer medicine·2025
Same author

Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

BMC pulmonary medicine·2024

Related Experiment Video

Updated: Mar 21, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.6K

TUBERCULOSIS AND LUNG CANCER.

Atsuhisa Tamura

    Kekkaku : [Tuberculosis]
    |May 20, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Pulmonary tuberculosis (PTB) and lung cancer frequently co-occur, with lung cancer often developing in PTB scars. Early diagnosis and treatment strategies must consider both diseases to overcome clinical challenges like delayed diagnosis and therapeutic limitations.

    More Related Videos

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    19.4K
    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    2.4K

    Related Experiment Videos

    Last Updated: Mar 21, 2026

    A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
    10:10

    A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

    Published on: October 5, 2015

    19.6K
    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    19.4K
    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    2.4K

    Area of Science:

    • Oncology
    • Infectious Diseases
    • Public Health

    Background:

    • Pulmonary tuberculosis (PTB) and lung cancer share a significant epidemiological link, with lung cancer historically recognized as a successor to PTB, often arising in scarred lung tissue.
    • Recent research highlights the connection through chronic inflammation-associated carcinogenesis, emphasizing the clinical relevance of these comorbidities.

    Purpose of the Study:

    • To review the epidemiological connection between PTB and lung cancer.
    • To discuss the clinical challenges and therapeutic limitations in managing patients with both conditions.
    • To emphasize the importance of considering concurrent PTB in lung cancer patients and vice versa.

    Main Methods:

    • Literature review of studies discussing PTB and lung cancer comorbidities.
    • Analysis of epidemiological data on the co-occurrence of active PTB in lung cancer cases and vice versa.
    • Examination of clinical challenges, including diagnostic delays and treatment limitations.

    Main Results:

    • Active PTB occurs in 2-5% of lung cancer cases, and lung cancer in 1-2% of active PTB cases.
    • Lung cancer in PTB patients is often advanced (Stage III-IV) and predominantly squamous cell carcinoma.
    • Clinical challenges include delayed diagnosis due to radiographic interpretation issues and therapeutic limitations such as M. tuberculosis infectivity, anatomical damage, and drug-drug interactions.

    Conclusions:

    • The comorbidity of PTB and lung cancer presents significant clinical challenges in Japan.
    • Awareness of concurrent PTB is crucial during lung cancer treatment, and conversely, lung cancer must be considered in PTB patients.
    • Integrated management strategies are needed to address diagnostic and therapeutic complexities.